4.38
Maravai Lifesciences Holdings Inc Aktie (MRVI) Neueste Nachrichten
Maravai (MRVI) officer granted 5,006 ESPP shares at $1.79 - Stock Titan
Maravai Lifesciences (NASDAQ: MRVI) counsel gets 776 ESPP shares - Stock Titan
Maravai LifeSciences To Attend The Jefferies Global Healthcare Conference - Business Wire
Maravai LifeSciences: Better Earnings Drive Gains That Ought To Be Sustainable (MRVI) - Seeking Alpha
Maravai LifeSciences Holdings, Inc.Class A common stock (NQ: MRVI - The Chronicle-Journal
Maravai LifeSciences Holdings, Inc. Sued for Securities Law Viola - The National Law Review
Maravai LifeSciences Holdings (MRVI) price target increased by 23.91% to 5.81 - MSN
12 West Capital Amends 13G, Holds 7.26M Shares in Maravai (MRVI) - Stock Titan
Maravai LifeSciences Q1 Turnaround Spurs Rethink Of CleanCap Driven Outlook - Sahm
How The Maravai LifeSciences (MRVI) Narrative Is Shifting With New Targets And 2026 Guidance - Yahoo Finance
Maravai LifeSciences stock (US56600D1072): Q1 turnaround and CleanCap momentum draw fresh investor a - AD HOC NEWS
Stuart Feldman-led group reports 9.21% stake in Maravai (MRVI) - Stock Titan
Millennium group lists 4.9% holding in Maravai (NASDAQ: MRVI) on 13G - Stock Titan
TradingKey - TradingKey
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q1 2026 Earnings Call Transcript - Insider Monkey
Maravai Lifesciences Signals Turnaround in Earnings Call - TipRanks
MRVI (Maravai) EPS crushes estimates by 121%, but shares fall 3% despite profit surprise.Brand Strength - Newser
Maravai (MRVI) Q1 2026 Earnings Transcript - AOL.com
All you need to know about Maravai LifeSciences (MRVI) rating upgrade to buy - MSN
Maravai LifeSciences Holdings, Inc. Q1 2026 Financial Results, Risks, and Forward-Looking Statements - Minichart
Maravai LifeSciences Holdings, Inc. (MRVI) tops Q1 earnings and revenue estimates - MSN
Maravai Q1 2026 slides: 41% revenue surge drives profitability return By Investing.com - Investing.com South Africa
Maravai LifeSciences Holdings (MRVI) EPS Loss Deepens Narrative On Persistent Profitability Concerns - simplywall.st
Maravai LifeSciences (NASDAQ: MRVI) boosts Q1 revenue, cuts debt - Stock Titan
Maravai LifeSciences Is Maintained at Overweight by Wells Fargo - Moomoo
Craig-Hallum Maintains Maravai LifeSciences(MRVI.US) With Buy Rating, Announces Target Price $5 - Moomoo
MRVI Maintained by Wells Fargo -- Price Target Raised to $5.50 - GuruFocus
12 Health Care Stocks Moving In Friday's Intraday SessionAIM ImmunoTech (AMEX:AIM), Akanda (NASDAQ:AKA - Benzinga
Wells Fargo & Company Forecasts Strong Price Appreciation for Maravai LifeSciences (NASDAQ:MRVI) Stock - MarketBeat
Deutsche Bank Maintains Maravai LifeSciences(MRVI.US) With Buy Rating, Cuts Target Price to $6 - Moomoo
Maravai LifeSciences Holdings, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Maravai LifeSciences Q1 Earnings Call Highlights - Barchart
Maravai LifeSciences Reports First Quarter 2026 Financial Results - BioSpace
Maravai Q1 2026 slides: 41% revenue surge drives profitability return - Investing.com
Earnings call transcript: Maravai Lifesciences Q1 2026 beats forecasts, stock rises By Investing.com - Investing.com South Africa
Earnings call transcript: Maravai Lifesciences Q1 2026 beats forecasts, stock rises - Investing.com Australia
Maravai LifeSciences Holdings, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:MRVI) 2026-05-07 - Seeking Alpha
Maravai LifeSciences Holdings Q1 2026 earnings preview - MSN
Maravai LifeSciences Holdings, Inc. (MRVI) Tops Q1 Earnings and Revenue Estimates - Yahoo Finance
Maravai LifeSciences Surges on Strong Q1, Raises Full-Year Outlook - BriefGlance
Maravai LifeSciences (NASDAQ:MRVI) Surges After Crushing Q1 Estimates and Raising Full-Year Guidance - ChartMill
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Q1 2026 Maravai LifeSciences Holdings Inc Earnings Call Transcript - GuruFocus
Maravai (NASDAQ: MRVI) lifts 2026 outlook after 41% Q1 revenue surge - Stock Titan
How many employees work at Maravai Lifesciences? - Revelio Labs
All You Need to Know About Maravai LifeSciences (MRVI) Rating Upgrade to Buy - Yahoo Finance
Maravai (MRVI) Stock: Price Pattern Formation | Maravai posts 44.7% EPS beat on narrower Q4 lossBest Pick - Newser
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):